Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Elnaz Khodabandehloo
Institution:
Hamedan University of Medical Sciences
Observed institutions:
Hamedan University of Medical Sciences,
Digestive Disease Research Institute,
Tehran University of Medical Sciences
ORCID:
0009-0001-5908-6078
Observed ORCID:
0009-0001-5908-6078
OpenAlex ID:
A5099087484
Progress and pitfalls of gene editing technology in CAR-T cell therapy: a state-of-the-art review
2024
·
Vahid Moradi
, Elnaz Khodabandehloo
, et al.
·
Frontiers in Oncology
·
48
Combining the induced pluripotent stem cell (iPSC) technology with chimeric antigen receptor (CAR)-based immunotherapy: recent advances, challenges, and future prospects
2024
·
Mehdi Alidadi
, Haniyeh Barzgar
, et al.
·
Frontiers in Cell and Developmental Biology
·
41
Harnessing the potential of gene editing technology for CAR-T cell therapy of solid tumors
2025
·
Elnaz Khodabandehloo
, Mohammad Rayati
, et al.
·
Inflammation and Regeneration
·
15
PDF
The role of non-coding RNAs in the regulation of cell death pathways in melanoma
2025
·
Yekta Metanat
, Maria Sviridova
, et al.
·
Discover Oncology
·
11
PDF
Emerging strategies to reduce the side effects of CAR-T cell therapy: focusing on gene editing and nanotechnology
2026
·
Jinxin Dong
, Denis Andreevich Nikolenko
, et al.
·
Clinical & Translational Oncology
·
7
Non-coding RNAs-mediated regulation of the MAPK pathway in gastric cancer: translational perspectives
2025
·
Darmadi Darmadi
, Komeil Aghazadeh-Habashi
, et al.
·
Discover Oncology
·
2
PDF
Show more works
View as search
Works count:
6
Citation count:
124
H-index:
5
I10-index:
4
Year
Topic
Type